Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Reading Time: 2 minutes Seattle, United States: Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits for both cells and nuclei. The new kits empower researchers who have a
Lundin Gold Reports Additional High-Grade Drilling Intercepts at FDNS And Updates on Conversion Drilling Program
Reading Time: 14 minutes Recent drilling results confirm the continuity and growth potential of FDNS as a new high-grade system across the south of FDN VANCOUVER, BC, November 4, 2024 /CNW/ – Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) (“Lundin Gold” or
Fondia Plc: Share repurchase 4.11.2024
Reading Time: < 1 minute Fondia Plc Company release 4.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 4.11.2024 Fondia Plc First North Finland Date 4.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 241 Average price/share, EUR 5,981120
Etrion Releases Third Quarter 2024 Results
Reading Time: 3 minutes November 4, 2024, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended
Neste, Alterra and Technip Energies collaborate to offer standardized solution to build chemical recycling plants
Reading Time: 4 minutes Neste Corporation, Press Release, 4 November 2024 at 7.00 p.m. (EET) Photo: Alterra’s Akron Plant in Ohio, 2024. Source: Alterra The partners aim to globally offer a standardized modular solution, based on Alterra’s proprietary discarded plastic liquefaction technology, to parties interested
Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc
Reading Time: 3 minutes The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. Reg. No 2825194-4 (the “Company”) was held on November 4, 2024, in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters. For immediate release Seinäjoki, Finland, November 4,
Greenfood AB (publ) gives notice for conditional early redemption of its notes 2021/2025
Reading Time: 2 minutes Greenfood AB (publ) (the “Company”) today informed the holders of its up to SEK 1,300,000,000 senior secured sustainability-linked floating rate notes 2021/2025 with ISIN SE0017072457 issued by the Company (the “Notes”) of its intention to redeem the Notes early, conditional upon the
Notification under Chapter 9, Section 10 of the Finnish Securities Market Act
Reading Time: < 1 minute Neste Corporation, Stock Exchange Release, 4 November 2024 at 7.30 p.m. (EET) Neste Corporation has today received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). According to the notification, the aggregate holdings including financial instruments according to SMA 9:6a
#24-378 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
BioStock: Medivir signs new clinical trial collaboration with Eisai
Reading Time: < 1 minute Mon, Nov 04, 2024 16:41 CET Report this content Medivir has entered into a clinical trial collaboration and supply agreement with Eisai to evaluate its liver-targeted treatment, fostrox, in combination with lenvatinib for advanced liver cancer. This partnership